These two fungal metabolites lower blood cholesterol levels and are members of an important class of drugs used clinically to treat elevated blood levels of cholesterol, a condition that is a significant risk factor for coronary artery disease. Our route to compactin and mevinolin was patented. During the synthesis a new reagent for making olefins was discovered, and later used in a general route to cyclic compounds.